Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

v2.4.0.8
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2013 $ (5,345,092) $ 27 $ 197,249 $ (5,542,368)
Balance (in shares) at Dec. 31, 2013   2,708,217    
Stock-based compensation - amortization of stock options 745,305 0 745,305 0
Stock-based compensation - amortization of IR consultant warrant 159,573 0 159,573 0
Stock-based compensation - amortization of consultant restricted stock units ("RSUs") 7,626 0 7,626 0
Issuance of shares to strategic investor, net of commission expense 900,000 2 899,998 0
Issuance of shares to strategic investor, net of commission expense (in shares)   210,527    
Initial public offering on April 2, 2014, net of underwriter's discount and offering costs of $2,816,149 24,783,851 46 24,783,805 0
Initial public offering on April 2, 2014, net of underwriter's discount and offering costs of $2,816,149 (in shares)   4,600,000    
Conversion of convertible notes on April 2, 2014 26,790,177 19 26,790,158 0
Conversion of convertible notes on April 2, 2014 (in shares)   1,930,128    
Sale of IPO Underwriter Warrant on April 2, 2014 1,000 0 1,000 0
Sale of IPO Underwriter Warrant on April 2, 2014 (in shares)   0    
Extinguishment of derivative for consulting warrant and financing warrant on June 25, 2014 5,752,000 0 5,752,000 0
Net loss (30,731,102) 0 0 (30,731,102)
Balance at Jun. 30, 2014 $ 23,063,338 $ 94 $ 59,336,714 $ (36,273,470)
Balance (in shares) at Jun. 30, 2014   9,448,872